Compass Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 05/15/2026 | 16.79 M | $88.82 M | 0.00% | 10.65% |
| ORBIMED ADVISORS LLC | 05/15/2026 | 15.22 M | $80.51 M | 0.00% | 9.65% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 05/15/2026 | 14.31 M | $75.69 M | 0.88% | 9.07% |
| VIVO CAPITAL, LLC | 05/20/2026 | 9.55 M | $50.50 M | 0.00% | 6.05% |
| BLACKROCK, INC. | 05/13/2026 | 9.51 M | $50.29 M | 1.25% | 6.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2026 | 8.49 M | $44.89 M | 91.29% | 5.38% |
| ENAVATE SCIENCES GP, LLC | 05/15/2026 | 7.79 M | $41.20 M | 0.00% | 4.94% |
| BVF INC/IL | 05/15/2026 | 7.76 M | $41.08 M | 0.00% | 4.92% |
| STATE STREET CORP | 05/15/2026 | 6.69 M | $35.42 M | 36.90% | 4.25% |
| 05/15/2026 | 6.04 M | $31.94 M | 100.00% | 3.83% | |
| RTW INVESTMENTS, LP | 05/15/2026 | 4.19 M | $22.15 M | 67.46% | 2.65% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 05/15/2026 | 3.61 M | $19.08 M | 0.00% | 2.29% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 3.57 M | $18.87 M | 1.81% | 2.26% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 05/15/2026 | 3.31 M | $17.49 M | -15.84% | 2.10% |
| LOGOS GLOBAL MANAGEMENT LP | 05/15/2026 | 3.15 M | $16.66 M | 173.91% | 2.00% |
| BLUE OWL CAPITAL HOLDINGS LP | 05/14/2026 | 2.94 M | $15.56 M | -15.14% | 1.87% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 2.55 M | $13.49 M | 477.26% | 1.62% |
| UBS GROUP AG | 05/05/2026 | 2.39 M | $12.65 M | 1,324.63% | 1.52% |
| SOFINNOVA INVESTMENTS, INC. | 05/15/2026 | 2.06 M | $10.88 M | -38.90% | 1.30% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 2.00 M | $10.56 M | 31.50% | 1.27% |
| BRAIDWELL LP | 05/15/2026 | 1.97 M | $10.40 M | -29.48% | 1.25% |
| BLACKSTONE INC. | 05/15/2026 | 1.86 M | $9.83 M | -69.67% | 1.18% |
| FMR LLC | 05/15/2026 | 1.80 M | $9.53 M | -30.16% | 1.14% |
| ROYCE & ASSOCIATES LP | 05/12/2026 | 1.62 M | $8.57 M | 466.39% | 1.03% |
| AMERIPRISE FINANCIAL INC | 05/15/2026 | 1.60 M | $8.45 M | 93.98% | 1.01% |
| PALO ALTO INVESTORS LP | 05/15/2026 | 1.51 M | $8.01 M | -40.20% | 0.96% |
| BIRCHVIEW CAPITAL, LP | 05/15/2026 | 1.47 M | $7.75 M | -7.98% | 0.93% |
| CAPTION MANAGEMENT, LLC | 05/15/2026 | 1.36 M | $7.19 M | 100.00% | 0.86% |
| GREAT POINT PARTNERS LLC | 05/15/2026 | 1.35 M | $7.14 M | 100.00% | 0.86% |
| FISHER ASSET MANAGEMENT, LLC | 05/05/2026 | 1.35 M | $7.13 M | 100.00% | 0.86% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2026 | 1.12 M | $5.92 M | -29.76% | 0.71% |
| 05/08/2026 | 1.08 M | $5.73 M | 100.00% | 0.69% | |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2026 | 1.08 M | $5.69 M | 137.82% | 0.68% |
| NORTHERN TRUST CORP | 05/14/2026 | 1.05 M | $5.55 M | 7.77% | 0.66% |
| ALLY BRIDGE GROUP (NY) LLC | 05/18/2026 | 1.00 M | $5.29 M | 100.00% | 0.63% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 998.14 K | $5.28 M | 100.00% | 0.63% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 865.61 K | $4.58 M | 224.89% | 0.55% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 05/14/2026 | 859.05 K | $4.54 M | -18.29% | 0.54% |
| ACUTA CAPITAL PARTNERS, LLC | 05/15/2026 | 849.08 K | $4.49 M | -22.34% | 0.54% |
| 05/14/2026 | 848.20 K | $4.49 M | -23.86% | 0.54% | |
| JPMORGAN CHASE & CO | 05/13/2026 | 847.70 K | $4.32 M | -2.56% | 0.54% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 846.22 K | $4.48 M | -72.78% | 0.54% |
| Y-INTERCEPT (HONG KONG) LTD | 04/27/2026 | 828.88 K | $4.38 M | 79.35% | 0.53% |
| BARCLAYS PLC | 05/15/2026 | 790.04 K | $4.18 M | 32.83% | 0.50% |
| CITADEL ADVISORS LLC | 05/15/2026 | 721.41 K | $3.82 M | 582.62% | 0.46% |
| BURKEHILL GLOBAL MANAGEMENT, LP | 05/15/2026 | 700.00 K | $3.70 M | 0.00% | 0.44% |
| CITIGROUP INC | 05/11/2026 | 598.24 K | $3.16 M | 128.44% | 0.38% |
| 06/04/2026 | 516.97 K | $2.73 M | -9.10% | 0.33% | |
| ARROWMARK COLORADO HOLDINGS LLC | 05/15/2026 | 514.79 K | $2.72 M | 100.00% | 0.33% |
| SOFINNOVA INVESTMENTS, INC. | 05/15/2026 | 500.00 K | $2.65 M | 100.00% | 0.32% |
Compass Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 217 institutional investors and hedge funds held shares of Compass Therapeutics Inc. The most heavily invested institutionals were:
TANG CAPITAL MANAGEMENT LLC: 16.79 M
ORBIMED ADVISORS LLC: 15.22 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 14.31 M
Vivo Capital, LLC: 9.55 M
BlackRock, Inc.: 9.51 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 8.49 M
109.86% of Compass Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 183.53 M shares in the last 24 months. This purchase volume represents approximately $994.75 M in transactions.